Capricor Therapeutics Inc. (CAPR)
NASDAQ · Healthcare
Capricor Therapeutics Inc. Revenue 2011–2025
Capricor Therapeutics Inc. annual/quarterly revenue history and growth rate from 2011 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Capricor Therapeutics Inc. revenue for the quarter ending September 30, 2024 was 2.3 M, a 63.44% decrease year-over-year.
- Capricor Therapeutics Inc. revenue for the twelve months ending September 30, 2024 was 17.3 M, a 99.15% increase year-over-year.
- Capricor Therapeutics Inc. annual revenue for 2025 was 0, a 100.00% decrease from 2024.
- Capricor Therapeutics Inc. annual revenue for 2024 was 22.3 M, a 11.55% decrease from 2023.
- Capricor Therapeutics Inc. annual revenue for 2023 was 25.2 M, a 886.81% increase from 2022.
- Capricor Therapeutics Inc. annual revenue for 2022 was 2.6 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Capricor Therapeutics Inc. (CAPR) — Frequently Asked Questions
Capricor Therapeutics Inc. (CAPR) is a publicly traded US company. It has a market capitalization of $1.16B. Explore CAPR's stock price, financial statements, earnings history, margins and key ratios below.
What is Capricor Therapeutics Inc.'s market cap?
Capricor Therapeutics Inc. (CAPR) has a market capitalization of $1.16B.
What is the CAPR stock price?
CAPR trades at $25.03 (-1.18% on the day).
Is CAPR profitable?
In fiscal 2025, Capricor Therapeutics Inc. reported net income of -$105M.